Anti-cN1A autoantibody seropositivity is associated with increased mortality risk in inclusion body myositis

被引：0

作者：

Lilleker, J. ^{[1
,2
]}

Rietveld, A. ^{[3
]}

Badrising, U. A. ^{[4
]}

Benveniste, O. ^{[5
]}

Gheorghe, K. R. ^{[6
]}

Hanna, M. G. ^{[7
]}

Herbert, M. K. ^{[8
,9
]}

Hilton-Jones, D. ^{[10
]}

Lamb, J. ^{[11
]}

Lecky, B. ^{[12
]}

Lundberg, I. E. ^{[6
]}

Machado, P. ^{[7
]}

Mariampillai, K. ^{[5
]}

Miller, J. ^{[13
]}

Parton, M. ^{[7
]}

Peeters, M. T. J. ^{[3
]}

Pye, S. ^{[1
]}

Roberts, M. E. ^{[2
]}

Sacconi, S. ^{[1
,14
]}

Saris, C. G. ^{[3
]}

Cooper, R. G. ^{[2
,11
]}

Pruijn, G. J. M. ^{[8
,9
,15
]}

Chinoy, H. ^{[1
,2
]}

van Engelen, B. G. M. ^{[3
]}

机构：

[1] Univ Manchester, Ctr Musculoskeletal Res, Manchester, Lancs, England

[2] Salford Royal NHS Fdn Trust, Salford, Lancs, England

[3] Radboud Univ Nijmegen, Med Ctr, Ctr Neurosci Donders, Dept Neurol,Inst Brain Cognit & Behav, Nijmegen, Netherlands

[4] Leiden Univ, Dept Neurol, Med Ctr, Leiden, Netherlands

[5] La Pitie Salpetriere Hosp, Dept Internal Med, Paris, France

[6] Karolinska Inst, Karolinska Univ Hosp, Rheumatol Unit, Dept Med, Stockholm, Sweden

[7] UCL, MRC Ctr Neuromuscular Dis, London, England

[8] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Dept Biomol Chem, Nijmegen, Netherlands

[9] Radboud Univ Nijmegen, Inst Mol & Mat, Nijmegen, Netherlands

[10] Oxford Univ Hosp, Nuffield Dept Clin Neurosci, Oxford, England

[11] Univ Manchester, Ctr Integrated Genom Med Res, Manchester, Lancs, England

[12] Walton Ctr Neurol & Neurosurg, Liverpool, Merseyside, England

[13] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England

[14] Nice Univ Hosp, Peripheral Nervous Syst Muscle & ALS Dept, Nice, France

[15] Univ Liverpool, MRC ARUK Inst Ageing & Chron Dis, Liverpool, Merseyside, England

来源：

NEUROMUSCULAR DISORDERS | 2016年 / 26卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P103

引用

页码：S35 / S35

页数：1

共 50 条

[31] Anti-NT5c1A Autoantibodies as Biomarkers in Inclusion Body Myositis
Amlani, Adam
Choi, May Y.
Tarnopolsky, Mark
Brady, Lauren
Clarke, Ann E.
Garcia-De La Torre, Ignacio
Mahler, Michael
Schmeling, Heinrike
Barber, Claire E.
Jung, Michelle
Fritzler, Marvin J.
FRONTIERS IN IMMUNOLOGY, 2019, 10
[32] The first inclusion body myositis-specific autoantibody: Anti-MUP44 targets the cytosolic 5′-nucleotidase IA
van Engelen, B. G. M.
Pluk, H.
Pruijn, G.
NEUROMUSCULAR DISORDERS, 2012, 22 (9-10) : 875 - 875
[33] Increased expression of transglutaminases 1 and 2 colocalizes with amyloid deposition in muscle of inclusion body myositis
Kim, S
Steinert, P
Choi, YC
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1999, 112 (04) : 633 - 633
[34] Association study reveals novel genetic risk factors associated with sporadic inclusion body myositis
Johan, M.
Arumilli, M.
Sandholm, N.
Lohi, H.
Hackman, P.
Udd, B.
NEUROMUSCULAR DISORDERS, 2016, 26 : S162 - S162
[35] ANTI-CYTOSOLIC 5'-NUCLEOTIDASE 1A (CN1A) ANTIBODY IN DIAGNOSIS OF INCLUSION BODY MYOSITIS: AN ITALIAN REAL-LIFE CASE SERIES
Conticini, Edoardo
Porcelli, Brunetta
Volpi, Nila
Bacarelli, Maria Romana
d'Alessandro, Miriana
Grazzini, Silvia
Bargagli, Elena
Cantarini, Luca
Frediani, Bruno
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 501 - 501
[36] Sporadic inclusion body myositis correlates with increased expression and cross-linking by transglutaminases 1 and 2
Choi, YC
Park, GT
Kim, TS
Sunwoo, IN
Steinert, PM
Kim, SY
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) : 8703 - 8710
[37] NKG2D ORCHESTRATES NATURAL KILLER CELL ACTIVATION AND INVASION IN INCLUSION BODY MYOSITIS IN ASSOCIATION WITH ANTI-CN1A-ANTIBODY STATUS
Schroeter, Christina B.
Nelke, Christopher
Pawlitzki, Marc
Muentefering, Thomas
Schaenzer, Anne
Stenzel, Werner
Meuth, Sven G.
Ruck, Tobias
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 499 - 500
[38] Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis
Gang, Qiang
Bettencourt, Conceicao
Machado, Pedro M.
Brady, Stefen
Holton, Janice L.
Pittman, Alan M.
Hughes, Deborah
Healy, Estelle
Parton, Matthew
Hilton-Jones, David
Shieh, Perry B.
Needham, Merrilee
Liang, Christina
Zanoteli, Edmar
de Camargo, Leonardo Valente
De Paepe, Boel
De Bleecker, Jan
Shaibani, Aziz
Ripolone, Michela
Violano, Raffaella
Moggio, Maurizio
Barohn, Richard J.
Dimachkie, Mazen M.
Mora, Marina
Mantegazza, Renato
Zanotti, Simona
Singleton, Andrew B.
Hanna, Michael G.
Houlden, Henry
NEUROBIOLOGY OF AGING, 2016, 47 : 218.e1 - 218.e9
[39] A SQSTM1 POLYMORPHISM CONFERS RISK FOR SPORADIC INCLUSION BODY MYOSITIS DISEASE EXPRESSION
Pytte, Julia
Van Loenhout, Maria
Mastaglia, Frank
James, Ian
Flynn, Loren L.
MacDougall, Gabriella
Beer, Kelly
Coudert, Jerome
Sooda, Anu
Akkari, P. Anthony
Needham, Merilee
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (02) : 438 - 438
[40] ANTI- C N1A ANTIBODIES IN SOUTH AUSTRALIAN PATIENTS WITH INCLUSION BODY MYOSITIS
Limaye, Vidya S.
Lester, Sue
Blumbergs, Peter
Greenberg, Steven A.
MUSCLE & NERVE, 2016, 53 (04) : 654 - 655

← 1 2 3 4 5 →